HbA1c may independently Predict MACE in Non-Diabetic STEMI Patients: Study
Researchers have found in a new study that HbA1c ma serve as an independent predictor of major adverse cardiovascular events (MACE) in non-diabetic STEMI patients. The study emphasized that blood glucose control in pre-diabetic STEMI patients was crucial for improving prognosis after percutaneous coronary intervention.
A study was done to investigate the relationship between glycosylated hemoglobin (HbA1c) concentration at admission and the prognosis of acute ST-segment elevation myocardial infarction (STEMI) in non-diabetic patients. A total of 142 non-diabetic patients with acute STEMI who underwent emergency percutaneous coronary intervention (PCI) in our hospital between January 2023 and December 2024 were enrolled in this study. HbA1c levels and baseline data for all patients were obtained at admission.
According to the HbA1c level, patients were divided into a normal blood glucose level group (group A, HbA1c & lt; 5.7%, N = 57) and a pre-diabetic group (group B, 5.7% ≤ HbA1c ≤ 6.4%, N = 85). The occurrence of major cardiovascular events (MACE) was compared between the two groups after PCI during one-year follow-up. Results: The levels of serum FPG, BNP and the number of patients with multivessel diseases in group B were higher than those in group A (all p < 0.05).
The LVEF in group B was significantly lower than in Group A (P = 0. 017). The total incidence of major cardiovascular events (MACE) within 1 year after percutaneous coronary intervention was significantly higher in group B than in group A (P = 0. 047). In addition, the risk of MACE in group B was 4.98 times higher than that in group A. HbA1c can be used as an independent predictor of MACE in non-diabetic STEMI patients. The control of blood glucose levels in pre-diabetic patients with STEMI should be given high emphasis to improve prognosis after percutaneous coronary intervention.
Reference:
Liu Z, Gao J, Hu W, Yan P, Lu J, Lei T, Xia J. Relationship Between Glycosylated Hemoglobin Concentration and Prognosis of Acute ST-Segment Elevation Myocardial Infarction in Non-Diabetic Patients. Int J Gen Med. 2025;18:3185-3192 https://doi.org/10.2147/IJGM.S519923
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.